{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T02:44:49Z","timestamp":1792464289069,"version":"4.5.0"},"reference-count":102,"publisher":"Elsevier BV","issue":"35","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100004423","name":"World Health Organization","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004423","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.vaccine.2016.06.002","type":"journal-article","created":{"date-parts":[[2016,6,21]],"date-time":"2016-06-21T01:14:22Z","timestamp":1466471662000},"page":"4110-4118","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["A 16-year review of seroprevalence studies on measles and rubella"],"prefix":"10.1016","volume":"34","author":[{"given":"Wayne","family":"Dimech","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mick N.","family":"Mulders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2016.06.002_b0005","series-title":"Global Vaccine Action Plan: 2011\u20132020","author":"World Health Organization","year":"2013"},{"key":"10.1016\/j.vaccine.2016.06.002_b0010","series-title":"Global measles and rubella strategic plan 2012\u20132020","author":"World Health Organization","year":"2012"},{"issue":"Suppl.","key":"10.1016\/j.vaccine.2016.06.002_b0015","first-page":"S36","article-title":"The 2001 serological survey in the Czech Republic\u2013measles","volume":"11","author":"Mrazova","year":"2003","journal-title":"Cent Eur J Public Health"},{"key":"10.1016\/j.vaccine.2016.06.002_b0020","first-page":"288","article-title":"The seroprevalence of IgG antibodies against rubella (German measles) in 10\u201349 year-old women from Cartagena, Colombia","volume":"13","author":"Mora-Garcia","year":"2011","journal-title":"Rev Salud Publica (Bogota)"},{"key":"10.1016\/j.vaccine.2016.06.002_b0025","series-title":"Immunization vaccine and biologicals","article-title":"Documenting the impact of Hepatitis B immunization: best practices for conducting a serosurvey","author":"World Health Organization","year":"2011"},{"key":"10.1016\/j.vaccine.2016.06.002_b0030","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1128\/CDLI.6.6.868-871.1999","article-title":"Decay of passively acquired maternal antibodies against measles, mumps, and rubella viruses","volume":"6","author":"Nicoara","year":"1999","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.vaccine.2016.06.002_b0035","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1097\/00006454-199907000-00003","article-title":"Rubella seroprevalence in an unvaccinated population in Izmir: recommendations for rubella vaccination in Turkey","volume":"18","author":"Aksit","year":"1999","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2016.06.002_b0040","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1093\/ije\/29.2.362","article-title":"Ten years of serological surveillance in England and Wales: methods, results, implications and action","volume":"29","author":"Osborne","year":"2000","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.vaccine.2016.06.002_b0045","doi-asserted-by":"crossref","first-page":"3106","DOI":"10.1016\/S0264-410X(00)00139-0","article-title":"Duration of rubella immunity induced by two-dose measles, mumps and rubella (MMR) vaccination. A 15-year follow-up in Finland","volume":"18","author":"Davidkin","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.06.002_b0050","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1016\/S0264-410X(00)00431-X","article-title":"Measles antibody responses after early two dose trials in Guinea-Bissau with Edmonston-Zagreb and Schwarz standard-titre measles vaccine: better antibody increase from booster dose of the Edmonston-Zagreb vaccine","volume":"19","author":"Garly","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.06.002_b0055","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1017\/S0950268801005830","article-title":"Impact of the Australian measles control campaign on immunity to measles and rubella","volume":"127","author":"Gilbert","year":"2001","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2016.06.002_b0060","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1017\/S0950268802007677","article-title":"Epidemiology of measles, mumps and rubella in Italy","volume":"129","author":"Gabutti","year":"2002","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2016.06.002_b0065","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S1201-9712(02)90135-9","article-title":"Measles IgG seroprevalence prior to mass vaccination in Taiwan","volume":"6","author":"Lee","year":"2002","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.vaccine.2016.06.002_b0070","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1023\/A:1022567811765","article-title":"Evaluation of the measles, mumps and rubella immunisation programme in Spain by using a sero-epidemiological survey","volume":"18","author":"Amela","year":"2003","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.vaccine.2016.06.002_b0075","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1017\/S0950268803008446","article-title":"Seroepidemiology of measles in Addis Ababa, Ethiopia: implications for control through vaccination","volume":"130","author":"Enquselassie","year":"2003","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2016.06.002_b0080","doi-asserted-by":"crossref","first-page":"2948","DOI":"10.1016\/S0264-410X(03)00113-0","article-title":"Immunity against measles in populations of women and infants in Poland","volume":"21","author":"Janaszek","year":"2003","journal-title":"Vaccine"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2016.06.002_b0085","first-page":"S123","article-title":"Persistence of vaccine-induced antibody to measles 26\u201333years after vaccination","volume":"189","author":"Dine","year":"2004","journal-title":"J Infect Dis"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2016.06.002_b0090","first-page":"S146","article-title":"Elimination of measles and of disparities in measles childhood vaccine coverage among racial and ethnic minority populations in the United States","volume":"189","author":"Hutchins","year":"2004","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2016.06.002_b0095","first-page":"1551","article-title":"Serosurvey of measles, mumps and rubella antibodies in Saudi children","volume":"26","author":"Al-Mazrou","year":"2005","journal-title":"Saudi Med J"},{"key":"10.1016\/j.vaccine.2016.06.002_b0100","doi-asserted-by":"crossref","first-page":"26","DOI":"10.4269\/ajtmh.2005.73.26","article-title":"A serosurvey to identify the window of vulnerability to wild-type measles among infants in rural Mali","volume":"73","author":"Tapia","year":"2005","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2016.06.002_b0105","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1086\/508826","article-title":"Seroprevalence survey of varicella, measles, rubella, and hepatitis A and B viruses in a multinational healthcare workforce in Saudi Arabia","volume":"27","author":"Almuneef","year":"2006","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.vaccine.2016.06.002_b0110","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1128\/JCM.00980-05","article-title":"Measles virus-specific antibody levels in individuals in Argentina who received a one-dose vaccine","volume":"44","author":"Arguelles","year":"2006","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2016.06.002_b0115","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.ajic.2006.04.213","article-title":"Measles, rubella, mumps, and varicella seroprevalence among health care workers in Turkey: is prevaccination screening cost-effective?","volume":"34","author":"Celikbas","year":"2006","journal-title":"Am J Infect Control"},{"key":"10.1016\/j.vaccine.2016.06.002_b0120","first-page":"63","article-title":"A serological survey of measles, mumps and rubella immunity among school aged children in Western Saudi Arabia","volume":"27","author":"Jaber","year":"2006","journal-title":"Saudi Med J"},{"key":"10.1016\/j.vaccine.2016.06.002_b0125","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1111\/j.1365-3083.2006.01857.x","article-title":"Prevalence of IgG antibody against measles, mumps and rubella in bangladeshi children: a pilot study to evaluate the need for integrated vaccination strategy","volume":"64","author":"Sultana","year":"2006","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.vaccine.2016.06.002_b0130","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1017\/S0950268806006340","article-title":"Interpreting serological surveys using mixture models: the seroepidemiology of measles, mumps and rubella in England and Wales at the beginning of the 21st century","volume":"134","author":"Vyse","year":"2006","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2016.06.002_b0135","doi-asserted-by":"crossref","first-page":"5772","DOI":"10.1016\/j.vaccine.2006.04.047","article-title":"Seroepidemiology study of rubella antibodies among pregnant women from seven Asian countries: evaluation of the rubella vaccination program in Taiwan","volume":"24","author":"Tseng","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.06.002_b0140","first-page":"283","article-title":"Seroprevalence of measles, mumps, rubella and varicella among staff of a hospital in Riyadh, Saudi Arabia","volume":"82","author":"Abbas","year":"2007","journal-title":"J Egypt Public Health Assoc"},{"key":"10.1016\/j.vaccine.2016.06.002_b0145","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1001\/archpedi.161.3.294","article-title":"Persistence of measles antibodies after 2 doses of measles vaccine in a postelimination environment","volume":"161","author":"LeBaron","year":"2007","journal-title":"Arch Pediatr Adolesc Med"},{"key":"10.1016\/j.vaccine.2016.06.002_b0150","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1097\/INF.0b013e31806211aa","article-title":"Distribution of serum measles-neutralizing antibodies according to age in women of childbearing age in France in 2005\u20132006: impact of routine immunization","volume":"26","author":"Pinquier","year":"2007","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2016.06.002_b0155","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1093\/eurpub\/ckm034","article-title":"Rubella immune status of indigenous and immigrant pregnant women in Catalonia, Spain","volume":"17","author":"Dominguez","year":"2007","journal-title":"Eur J Public Health"},{"key":"10.1016\/j.vaccine.2016.06.002_b0160","doi-asserted-by":"crossref","DOI":"10.2807\/ese.13.16.18841-en","article-title":"Measles and mumps immunity in Northern Greece, 2004\u20132007","volume":"13","author":"Fylaktou","year":"2008","journal-title":"Euro Surveill"},{"key":"10.1016\/j.vaccine.2016.06.002_b0165","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1128\/CVI.00229-08","article-title":"Kinetics of decline of maternal measles virus-neutralizing antibodies in sera of infants in France in 2006","volume":"15","author":"Gagneur","year":"2008","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2016.06.002_b0170","doi-asserted-by":"crossref","first-page":"787","DOI":"10.4269\/ajtmh.2008.79.787","article-title":"Measles-specific neutralizing antibodies in rural Mozambique: seroprevalence and presence in breast milk","volume":"79","author":"Mandomando","year":"2008","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2016.06.002_b0175","doi-asserted-by":"crossref","first-page":"4769","DOI":"10.1016\/j.vaccine.2008.07.005","article-title":"Evaluation of a measles vaccine campaign in Ethiopia using oral-fluid antibody surveys","volume":"26","author":"Nigatu","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.06.002_b0180","doi-asserted-by":"crossref","first-page":"4403","DOI":"10.1016\/j.vaccine.2008.05.094","article-title":"Measles serological survey in the Italian population: interpretation of results using mixture model","volume":"26","author":"Rota","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.06.002_b0185","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1007\/s00508-008-1005-6","article-title":"High seroprevalence of varicella, measles, mumps, rubella and pertussis antibodies in first-grade medical students","volume":"120","author":"Socan","year":"2008","journal-title":"Wien Klin Wochenschr"},{"key":"10.1016\/j.vaccine.2016.06.002_b0190","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s10096-008-0460-3","article-title":"Detection of measles- and mumps-specific IgG antibodies in paired serum and oral fluid samples from Norwegian conscripts","volume":"27","author":"Vainio","year":"2008","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.vaccine.2016.06.002_b0195","first-page":"451","article-title":"Prevalence of rubella and cytomegalovirus antibodies among pregnant women in northern Turkey","volume":"31","author":"Uyar","year":"2008","journal-title":"New Microbiol"},{"key":"10.1016\/j.vaccine.2016.06.002_b0200","first-page":"1036","article-title":"Age-specific rubella seroprevalence in unvaccinated adolescents in Ankara, Turkey","volume":"14","author":"Yalcin","year":"2008","journal-title":"East Mediterr Health J"},{"key":"10.1016\/j.vaccine.2016.06.002_b0205","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1017\/S0950268808000848","article-title":"Evaluation of a measles vaccine campaign by oral-fluid surveys in a rural Kenyan district: interpretation of antibody prevalence data using mixture models","volume":"137","author":"Ohuma","year":"2009","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2016.06.002_b0210","doi-asserted-by":"crossref","first-page":"80","DOI":"10.3329\/jhpn.v27i1.3320","article-title":"Seroprevalence of antibodies to measles, mumps, and rubella among Thai population: evaluation of measles\/MMR immunization programme","volume":"27","author":"Tharmaphornpilas","year":"2009","journal-title":"J Health Popul Nutr"},{"key":"10.1016\/j.vaccine.2016.06.002_b0215","first-page":"534","article-title":"Seroprevalence of rubella among Turkish women and children in Afyonkarahisar, Turkey","volume":"51","author":"Demirdal","year":"2009","journal-title":"Turk J Pediatr"},{"key":"10.1016\/j.vaccine.2016.06.002_b0220","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1086\/605410","article-title":"Persistence of rubella antibodies after 2 doses of measles-mumps-rubella vaccine","volume":"200","author":"LeBaron","year":"2009","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2016.06.002_b0225","first-page":"236","article-title":"Eliminating congenital rubella: a seroepidemiological study on women of childbearing age and MMR vaccine coverage in newborns","volume":"50","author":"Lo Giudice","year":"2009","journal-title":"J Prev Med Hyg"},{"key":"10.1016\/j.vaccine.2016.06.002_b0230","doi-asserted-by":"crossref","first-page":"8219","DOI":"10.1016\/j.vaccine.2010.07.071","article-title":"Low measles seropositivity rate among children and young adults: a sero-epidemiological study in southern China in 2008","volume":"28","author":"Fu","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.06.002_b0235","doi-asserted-by":"crossref","first-page":"7844","DOI":"10.1016\/j.vaccine.2010.09.082","article-title":"Seroprevalence of rubella in female migrant factory workers in Shenzhen, China","volume":"28","author":"Mou","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.06.002_b0240","doi-asserted-by":"crossref","first-page":"4485","DOI":"10.1016\/j.vaccine.2011.04.037","article-title":"A large observational study to concurrently assess persistence of measles specific B-cell and T-cell immunity in individuals following two doses of MMR vaccine","volume":"29","author":"Haralambieva","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.06.002_b0245","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.vaccine.2010.11.081","article-title":"Sero-epidemiology of measles in general population in Jiangsu province of China: application of mixture models to interpret the results from a cross-sectional study","volume":"29","author":"Liu","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.06.002_b0250","first-page":"237","article-title":"Seroprevalence of rubella and measles antibodies in Lao PDR","volume":"57","author":"Phengxay","year":"2011","journal-title":"Clin Lab"},{"key":"10.1016\/j.vaccine.2016.06.002_b0255","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1136\/annrheumdis-2011-200637","article-title":"Differences in persistence of measles, mumps, rubella, diphtheria and tetanus antibodies between children with rheumatic disease and healthy controls: a retrospective cross-sectional study","volume":"71","author":"Heijstek","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.vaccine.2016.06.002_b0260","doi-asserted-by":"crossref","first-page":"e42867","DOI":"10.1371\/journal.pone.0042867","article-title":"Seroprevalence of measles-, mumps- and rubella-specific IgG antibodies in German children and adolescents and predictors for seronegativity","volume":"7","author":"Poethko-Muller","year":"2012","journal-title":"PLoS ONE"},{"issue":"Suppl. 2","key":"10.1016\/j.vaccine.2016.06.002_b0265","doi-asserted-by":"crossref","first-page":"S664","DOI":"10.1093\/infdis\/jir356","article-title":"Serologic status of women in an urban population in Brazil before and after rubella immunization campaign using routine screening data","volume":"204","author":"Artimos de Oliveira","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2016.06.002_b0270","doi-asserted-by":"crossref","first-page":"140","DOI":"10.4103\/1119-3077.84002","article-title":"Seroprevalence survey of rubella infection in pregnancy at the University of Benin Teaching Hospital, Benin City, Nigeria","volume":"14","author":"Onakewhor","year":"2011","journal-title":"Niger J Clin Pract"},{"key":"10.1016\/j.vaccine.2016.06.002_b0275","doi-asserted-by":"crossref","first-page":"874","DOI":"10.3855\/jidc.1847","article-title":"Seroprevalence of rubella and immunogenicity following rubella vaccination in adolescent girls in India","volume":"5","author":"Sharma","year":"2011","journal-title":"J Infect Dev Countries"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2016.06.002_b0280","doi-asserted-by":"crossref","first-page":"S433","DOI":"10.1093\/infdis\/jir078","article-title":"Developing rubella vaccination policy in Nepal \u2013 results from rubella surveillance and seroprevalence and congenital rubella syndrome studies","volume":"204","author":"Upreti","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2016.06.002_b0285","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1017\/S0950268811000598","article-title":"Changes in measles seroepidemiology of healthcare workers in southern Taiwan","volume":"140","author":"Ho","year":"2012","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2016.06.002_b0290","doi-asserted-by":"crossref","first-page":"3355","DOI":"10.1016\/j.vaccine.2012.03.073","article-title":"Seroprevalence of measles among children affected by national measles elimination program in Korea, 2010","volume":"30","author":"Kim","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.06.002_b0295","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s00431-011-1569-4","article-title":"Antibody persistence for 3years following two doses of tetravalent measles-mumps-rubella-varicella vaccine in healthy children","volume":"171","author":"Knuf","year":"2012","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.vaccine.2016.06.002_b0300","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1016\/j.vaccine.2012.01.083","article-title":"Immunological impact of an additional early measles vaccine in Gambian children: responses to a boost at 3years","volume":"30","author":"Njie-Jobe","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.06.002_b0305","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.vaccine.2011.11.078","article-title":"Duration of maternally derived antibody against measles: a seroepidemiological study of infants aged under 8months in Qinghai, China","volume":"30","author":"Zhang","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.06.002_b0310","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/ajim.22046","article-title":"Prevalence of measles, mumps, rubella, and varicella susceptibility among health science students in a University in India","volume":"56","author":"Arunkumar","year":"2013","journal-title":"Am J Ind Med"},{"key":"10.1016\/j.vaccine.2016.06.002_b0315","doi-asserted-by":"crossref","first-page":"578","DOI":"10.5812\/jjm.4563","article-title":"Seroprevalence of measles, mumps and rubella Antibodies in 18months and 6.5years old children: 6months after measles-mumps-rubella (MMR) vaccination","volume":"5","author":"Shamsizadeh","year":"2012","journal-title":"Jundishapur J Microbiol"},{"key":"10.1016\/j.vaccine.2016.06.002_b0320","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.vaccine.2011.11.045","article-title":"Seroprevalence of low rubella IgG antibody levels among antenatal women in England tested by NHS Blood and Transplant: 2004\u20132009. Is rubella susceptibility increasing?","volume":"30","author":"Byrne","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.06.002_b0325","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1002\/jmv.23195","article-title":"Rubella immune status among immigrant and nonimmigrant women in Spain","volume":"84","author":"Ramos","year":"2012","journal-title":"J Med Virol"},{"key":"10.1016\/j.vaccine.2016.06.002_b0330","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1007\/s00404-012-2353-z","article-title":"Cytomegalovirus and rubella seroprevalence in pregnant women in Izmir\/Turkey: follow-up and results of pregnancy outcome","volume":"286","author":"Uysal","year":"2012","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.vaccine.2016.06.002_b0335","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.vaccine.2013.10.071","article-title":"Seroprevalence of measles and rubella antibodies in pregnant women Haiti, 2012","volume":"32","author":"Fitter","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.06.002_b0340","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1093\/infdis\/jis719","article-title":"Measles humoral and cell-mediated immunity in children aged 5\u201310years after primary measles immunization administered at 6 or 9months of age","volume":"207","author":"Gans","year":"2013","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2016.06.002_b0345","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.4161\/hv.25127","article-title":"Seroprevalence of antibodies against measles, rubella, mumps, varicella-zoster, and B. Pertussis in young adults of Madrid, Spain","volume":"9","author":"Gonzalez-Escalada","year":"2013","journal-title":"Hum Vaccine Immunother"},{"key":"10.1016\/j.vaccine.2016.06.002_b0350","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1186\/1471-2458-13-1211","article-title":"Measles vaccination coverage estimates from surveys, clinic records, and immune markers in oral fluid and blood: a population-based cross-sectional study","volume":"13","author":"Hayford","year":"2013","journal-title":"BMC Public Health"},{"key":"10.1016\/j.vaccine.2016.06.002_b0355","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.vaccine.2012.11.014","article-title":"Waning immunity to measles in young adults and booster effects of revaccination in secondary school students","volume":"31","author":"He","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.06.002_b0360","doi-asserted-by":"crossref","first-page":"e55043","DOI":"10.1371\/journal.pone.0055043","article-title":"Seroprevalence of anti-rubella and anti-measles IgG antibodies in pregnant women in Shiraz, Southern Iran: outcomes of a nationwide measles-rubella mass vaccination campaign","volume":"8","author":"Honarvar","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2016.06.002_b0365","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1111\/j.1447-0756.2012.01997.x","article-title":"Low titers of measles antibodies in Japanese pregnant women: a single-center study","volume":"39","author":"Kanda","year":"2013","journal-title":"J Obstet Gynaecol Res"},{"key":"10.1016\/j.vaccine.2016.06.002_b0370","doi-asserted-by":"crossref","first-page":"411","DOI":"10.7883\/yoken.66.411","article-title":"Seroprevalence of measles- and mumps-specific immunoglobulin G among Japanese healthcare students increased during 2007\u20132012","volume":"66","author":"Kimura","year":"2013","journal-title":"Jpn J Infect Dis"},{"key":"10.1016\/j.vaccine.2016.06.002_b0375","doi-asserted-by":"crossref","first-page":"e66771","DOI":"10.1371\/journal.pone.0066771","article-title":"Cross-sectional surveys of measles antibodies in the Jiangsu Province of China from 2008 to 2010: the effect of high coverage with two doses of measles vaccine among children","volume":"8","author":"Liu","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2016.06.002_b0380","doi-asserted-by":"crossref","first-page":"3683","DOI":"10.1016\/j.vaccine.2013.05.102","article-title":"Seroprevalence of measles, mumps and rubella among children in American Samoa, 2011, and progress towards West Pacific Region goals of elimination","volume":"31","author":"Mahamud","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.06.002_b0385","doi-asserted-by":"crossref","first-page":"5766","DOI":"10.1016\/j.vaccine.2013.08.044","article-title":"Measles antibody levels after vaccination with Edmonston-Zagreb and Schwarz measles vaccine at 9months or at 9 and 18months of age: a serological study within a randomised trial of different measles vaccines","volume":"31","author":"Martins","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.06.002_b0390","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1186\/1471-2334-13-391","article-title":"Prevalence of measles antibodies among health care workers in Catalonia (Spain) in the elimination era","volume":"13","author":"Urbiztondo","year":"2013","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.vaccine.2016.06.002_b0395","doi-asserted-by":"crossref","first-page":"449","DOI":"10.7883\/yoken.66.449","article-title":"Measles epidemiology and survey of measles immunity level among healthy population in Baoji City, Shaanxi Province, China","volume":"66","author":"Zhang","year":"2013","journal-title":"Jpn J Infect Dis"},{"key":"10.1016\/j.vaccine.2016.06.002_b0400","doi-asserted-by":"crossref","first-page":"O501","DOI":"10.1111\/1469-0691.12469","article-title":"Determinants of measles seroprevalence among pregnant women in Paris, France","volume":"20","author":"Bodilis","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.vaccine.2016.06.002_b0405","doi-asserted-by":"crossref","first-page":"812","DOI":"10.26719\/2013.19.9.812","article-title":"Seroprevalence of rubella among pregnant women in Khartoum state, Sudan","volume":"19","author":"Adam","year":"2013","journal-title":"East Mediterr Health J"},{"key":"10.1016\/j.vaccine.2016.06.002_b0410","first-page":"917","article-title":"Evaluation of rubella IgG antibodies among women at marriage in Kermanshah city, before and after mass vaccination","volume":"4","author":"Hatami","year":"2013","journal-title":"Int J Prev Med"},{"key":"10.1016\/j.vaccine.2016.06.002_b0415","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1590\/S0034-89102013000901080","article-title":"Seroprevalence of rubella in Colombia: a birth-year cohort analysis","volume":"47","author":"Hincapie-Palacio","year":"2013","journal-title":"Rev Saude Publica"},{"key":"10.1016\/j.vaccine.2016.06.002_b0420","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1186\/1471-2334-13-362","article-title":"Rubella immunity among prenatal women in Ontario, 2006\u20132010","volume":"13","author":"Lim","year":"2013","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.vaccine.2016.06.002_b0425","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1186\/1471-2334-13-164","article-title":"Rubella seroprevalence among pregnant women in Burkina Faso","volume":"13","author":"Tahita","year":"2013","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.vaccine.2016.06.002_b0430","doi-asserted-by":"crossref","first-page":"91","DOI":"10.7774\/cevr.2014.3.1.91","article-title":"Immunogenicity and safety of a tetravalent measles-mumps-rubella-varicella vaccine: an open-labeled, randomized trial in healthy Korean children","volume":"3","author":"Cha","year":"2014","journal-title":"Clin Exp Vaccine Res"},{"key":"10.1016\/j.vaccine.2016.06.002_b0435","doi-asserted-by":"crossref","first-page":"4001","DOI":"10.1016\/j.vaccine.2014.04.044","article-title":"Similar immunogenicity of measles-mumps-rubella (MMR) vaccine administrated at 8months versus 12months age in children","volume":"32","author":"He","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.06.002_b0440","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1017\/S0950268813000393","article-title":"Seroprevalence survey on measles, mumps, rubella and varicella antibodies in healthcare workers in Japan: sex, age, occupational-related differences and vaccine efficacy","volume":"142","author":"Kumakura","year":"2014","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2016.06.002_b0445","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1093\/infdis\/jiu117","article-title":"Measles virus antibody responses in children randomly assigned to receive standard-titer Edmonston-Zagreb measles vaccine at 4.5 and 9months of age, 9months of age, or 9 and 18months of age","volume":"210","author":"Martins","year":"2014","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2016.06.002_b0450","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1017\/S0950268813001532","article-title":"High risk of a large measles outbreak despite 30 years of measles vaccination in The Netherlands","volume":"142","author":"Mollema","year":"2014","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2016.06.002_b0455","doi-asserted-by":"crossref","first-page":"e89361","DOI":"10.1371\/journal.pone.0089361","article-title":"Difficulties in eliminating measles and controlling rubella and mumps: a cross-sectional study of a first measles and rubella vaccination and a second measles, mumps, and rubella vaccination","volume":"9","author":"Wang","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2016.06.002_b0460","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1017\/S0950268814002817","article-title":"Immunity to polio, measles and rubella in women of child-bearing age and estimated congenital rubella syndrome incidence, Cambodia, 2012","volume":"143","author":"Mao","year":"2015","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2016.06.002_b0465","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.4161\/hv.27734","article-title":"Age-related changes in serological susceptibility patterns to measles: results from a seroepidemiological study in Dongguan, China","volume":"10","author":"Xiong","year":"2014","journal-title":"Hum Vaccine Immunother"},{"key":"10.1016\/j.vaccine.2016.06.002_b0470","doi-asserted-by":"crossref","first-page":"389","DOI":"10.3855\/jidc.3854","article-title":"Seroprevalence of cytomegalovirus, herpes simplex virus and rubella virus among pregnant women in KPK province of Pakistan","volume":"8","author":"Ali","year":"2014","journal-title":"J Infect Dev Countries"},{"key":"10.1016\/j.vaccine.2016.06.002_b0475","doi-asserted-by":"crossref","first-page":"659838","DOI":"10.1155\/2014\/659838","article-title":"Rubella immunity among pregnant women in Jeddah, Western Region of Saudi Arabia","volume":"2014","author":"Alsibiani","year":"2014","journal-title":"Obstet Gynecol Int"},{"key":"10.1016\/j.vaccine.2016.06.002_b0480","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1002\/jmv.23757","article-title":"Susceptibility to cytomegalovirus, parvovirus B19 and age-dependent differences in levels of rubella antibodies among pregnant women","volume":"86","author":"Barlinn","year":"2014","journal-title":"J Med Virol"},{"key":"10.1016\/j.vaccine.2016.06.002_b0485","first-page":"287","article-title":"Seroprevalence of rubella IgG antibody in pregnant women in osogbo, Nigeria","volume":"5","author":"Kolawole","year":"2014","journal-title":"Int J Prev Med"},{"key":"10.1016\/j.vaccine.2016.06.002_b0490","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/1471-2393-14-95","article-title":"Sero-positivity rate of rubella and associated factors among pregnant women attending antenatal care in Mwanza, Tanzania","volume":"14","author":"Mwambe","year":"2014","journal-title":"BMC Preg Childbirth"},{"key":"10.1016\/j.vaccine.2016.06.002_b0495","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1016\/j.vaccine.2014.01.066","article-title":"Seroprevalence of rubella antibodies in The Netherlands after 32years of high vaccination coverage","volume":"32","author":"Smits","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.06.002_b0500","series-title":"Composition of macro geographical (continental) regions, geographical sub-regions, and selected economic and other groupings United Nations","author":"United Nations","year":"2013"},{"key":"10.1016\/j.vaccine.2016.06.002_b0505","doi-asserted-by":"crossref","first-page":"O566","DOI":"10.1111\/1469-0691.12530","article-title":"Monitoring progress toward measles elimination by genetic diversity analysis of measles viruses in China 2009\u20132010","volume":"20","author":"Zhang","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.vaccine.2016.06.002_b0510","series-title":"Revised WHO position on measles vaccine 2009","author":"World Health Organization","year":"2009"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16304017?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16304017?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,2]],"date-time":"2022-07-02T00:30:02Z","timestamp":1656721802000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X16304017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":102,"journal-issue":{"issue":"35","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["S0264410X16304017"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.06.002","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A 16-year review of seroprevalence studies on measles and rubella","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.06.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}